652983-04-5

1H-Indene-1-acetic acid,5-[2-(3,5-dimethyl-1H-pyrazol-1-yl)ethoxy]-2,3-dihydro-, (1S)-

1H-Indene-1-acetic acid,5-[2-(3,5-dimethyl-1H-pyrazol-1-yl)ethoxy]-2,3-dihydro-, (1S)-

Catalog No.2431741
Name 1H-Indene-1-acetic acid,5-[2-(3,5-dimethyl-1H-pyrazol-1-yl)ethoxy]-2,3-dihydro-, (1S)-
CAS652983-04-5
FormulaC18H22N2O3

Request a Quote

Structure of 652983-04-5

About 1H-Indene-1-acetic acid,5-[2-(3,5-dimethyl-1H-pyrazol-1-yl)ethoxy]-2,3-dihydro-, (1S)-

1H-Indene-1-acetic acid,5-[2-(3,5-dimethyl-1H-pyrazol-1-yl)ethoxy]-2,3-dihydro-, (1S)- is a chemical compound registered under CAS number 652983-04-5, with the molecular formula C18H22N2O3 and a molecular weight of about 314.38 g/mol. KingPharm Group supplies 1H-Indene-1-acetic acid,5-[2-(3,5-dimethyl-1H-pyrazol-1-yl)ethoxy]-2,3-dihydro-, (1S)- for laboratory research and bulk production; product code 2431741. Send an inquiry for purity, packaging, price and lead time.

CAS Number
652983-04-5
Molecular Formula
C18H22N2O3
Molecular Weight
314.38 g/mol

Related Products

  1. Benzene, 1-chloro-4-[chloro(4-methoxyphenyl)phenylmethyl]-
    154478-13-4
  2. 4-benzo[a]anthracen-12-ylpyridine
    2498-68-2
  3. 4-[(3S,5R)-5-(4-methoxyphenyl)-2,2-dimethylpyrrolidin-3-yl]pyridine dihydrochloride
    74650-29-6
  4. 11-O-Galloylnorbergenin
    82958-46-1
  5. CALPAIN INHIBITOR XI
    145731-49-3
  6. 2,2'-{[2-(7H-dibenzo[c,h]phenothiazin-7-yl)ethyl]imino}diethanol
    1457-33-6
  7. 3,6,9,12-Tetraoxapentacosanamide,N-[2-(dimethylamino)ethyl]-15-octyl-
  8. ETHYLENE GLYCOL 1,2-BIS(2-PROPYNYL) ETHER
  9. 3-butoxy-N-[2-(3,4-dimethylphenyl)-1,3-benzoxazol-5-yl]benzamide
  10. 1,2,3,4-Tetrahydroisoquinoline-8-carboxylic acid
  11. 652983-04-5 msds
  12. CAS No 652983-04-5 supplier
  13. CASNo 652983-04-5 distributor
  14. CAS # 652983-04-5 manufacturer
  15. CAS Number 652983-04-5 safety
  16. CAS RN 652983-04-5 wholesale
  17. 2026-10-27 Find 1H-Indene-1-acetic acid,5-[2-(3,5-dimethyl-1H-pyrazol-1-yl)ethoxy]-2,3-dihydro-, (1S)-,CAS No.652983-04-5,Formula:C18H22N2O3 in KingPharm Group